MarginsXMarginsX
Home › Markets › Health Care › IMTX

Immatics N.V. (IMTX)

IMTX trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$6.17
-3.44% on the day
Market cap
$923.2M
Small cap
Revenue
Foreign filer: no machine-readable annual figure in SEC data
Net income
Foreign filer: no machine-readable annual figure in SEC data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerIMTX on Nasdaq
SectorHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
CountryGermany
IPO yearNot reported by the screener
SEC CIK0001809196
SEC industry codeBiological Products, (No Diagnostic Substances)
Incorporated inNetherlands

Financials

Foreign filer: no machine-readable annual figure in SEC data.

Warning signs

Cash runway
23.5 months
345.9M EUR cash at December 31, 2025
Share count, 1 year
+10.3%
2024-12-31 to 2025-12-31 · +74.9% over 3 years
Going-concern doubt
No
20-F filed March 5, 2026
Insider net buying, 12 months
$7.5M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.20-F 2026-03-05
Cash and burn345.9M EUR cash; operating cash flow -44.2M EUR a quarter.Report 2025-12-31
Shares outstanding134,071,432 (2025-12-31); 121,550,169 a year earlier; 76,670,699 three years earlier. the newest SEC cover-page count is from 2025-12-31; shares issued since then are not in these figures.Cover page 2025-12-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 2 424B5 takedowns, 2 at the marketLatest 2025-12-05
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
Delisting25-NSE filed25-NSE 2025-07-01
AuditorPricewaterhouseCoopers GmbH Wirtschaftsprüfungsgesellschaft, Stuttgart, GermanyPCAOB Form AP 2026-03-27
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $7.5M, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2025
2025-12-31
Not filed-196.4M EUR-176.6M EUR345.9M EURNo debt tagsNeeds four quarters20-F 2026-03-05
FY 2024
2024-12-31
Not filed15.2M EUR-158.0M EUR236.7M EURNo debt tagsNeeds four quarters20-F 2026-03-05
FY 2023
2023-12-31
Not filed-94.6M EUR18.2M EUR218.5M EURNo debt tagsNeeds four quarters20-F 2025-03-27
FY 2022
2022-12-31
Not filed27.7M EUR100.1M EUR148.5M EURNo debt tagsNeeds four quarters20-F 2025-03-27
FY 2021
2021-12-31
Not filed-93.3M EUR-84.7M EUR133.0M EURNo debt tagsNeeds four quarters20-F 2023-03-22
FY 2020
2020-12-31
Not filed-211.3M EUR-80.7M EUR207.5M EURNo debt tagsNeeds four quarters20-F 2023-03-22
FY 2019
2019-12-31
Not filed-31.6M EUR71.0M EUR103.4M EURNo debt tagsNeeds four quarters20-F 2022-03-23
FY 2018
2018-12-31
Not filed-31.4M EUR20.7M EUR39.4M EURNo debt tagsNeeds four quarters20-F/A 2021-10-28

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months). Amounts in EUR.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B22026-08-25
Latest annual report20-F2026-03-05
Latest quarterly / interim6-K2026-11-10

Source: SEC EDGAR submissions feed, 248 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+0.5%
1 month-6.4%
3 months-33.4%
Year to date-39.1%
1 year-36.0%
From 52-week high-46.2%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Biological Products (No Diagnostic Substances)

TickerCompanyPriceDayMarket cap
ODTXOdyssey Therapeutics Inc.$19.36+1.15%$930.6M
MGTXMeiraGTx Holdings plc$8.74-4.79%$854.2M
GLUEMonte Rosa Therapeutics Inc.$9.16-2.24%$782.7M
PRMEPrime Medicine Inc.$4.19-1.87%$762.3M
AURAAura Biosciences Inc.$7.22+1.55%$751.4M
INBXInhibrx Biosciences Inc.$77.66-6.77%$1.1B
VORVor Biopharma Inc.$18.97-2.32%$1.2B
SLDBSolid Biosciences Inc.$6.48-5.26%$723.2M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier